Next Testosterone Lawsuit Conference in Federal Litigation Scheduled for December 8th, Bernstein Lie

The Firm is evaluating testosterone treatment lawsuits on behalf of men who allegedly suffered heart attacks, strokes, deep vein thrombosis, pulmonary embolism, and other serious cardiovascular problems due to their use of low testosterone therapy. New York, New York (PRWEB) November 01, 2014 The federal court overseeing hundreds of testosterone lawsuits (http://www.testosteronelawsuithub.com/) that allege drugs like AndroGel, Testim and Axiron caused patients to suffer serious cardiovascular injuries will convene the litigation’s next Case Management Conference on December 8th, 2014. Ac
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations